143 related articles for article (PubMed ID: 9524540)
1. [Acetylsalicylic acid in ischemic insult].
Noth J
Dtsch Med Wochenschr; 1998 Feb; 123(9):270. PubMed ID: 9524540
[No Abstract] [Full Text] [Related]
2. [Secondary prevention of cerebral ischemia. AMEVASC. Mexican Association of Cerebrovascular Disease].
Barinagarrementeria F; Amaya L; Guzmán JL; Ibarra O; Loy Mdel C; Millán R; Neri G; Villarreal J; Araúz A; Cantú C
Rev Invest Clin; 2002; 54(3):257-61. PubMed ID: 12183895
[No Abstract] [Full Text] [Related]
3. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
Vyshlov EV; Panfilova EV; Markov VA
Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
[TBL] [Abstract][Full Text] [Related]
4. [Anti-aggregation therapy for prevention of cerebral ischemic stroke: a risk benefit analysis].
Zarranz Imirizaldu JJ
Med Clin (Barc); 1997 Dec; 109(20):802-7. PubMed ID: 9493161
[No Abstract] [Full Text] [Related]
5. Facts and controversies of aspirin and clopidogrel therapy.
Faxon DP; Freedman JE
Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention of ischaemic stroke and TIA.
Diener HC
Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
[No Abstract] [Full Text] [Related]
7. Warfarin, aspirin, or both after myocardial infarction.
Amit G; Ilia R; Zahger D
N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530435
[No Abstract] [Full Text] [Related]
8. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
[TBL] [Abstract][Full Text] [Related]
9. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
[No Abstract] [Full Text] [Related]
10. Warfarin, aspirin, or both after myocardial infarction.
Pullicino P; Thompson JL
N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12529470
[No Abstract] [Full Text] [Related]
11. Warfarin, aspirin, or both after myocardial infarction.
Aronow WS
N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
[No Abstract] [Full Text] [Related]
12. [ASS plus clopidogrel in contraindication for marcumar].
Einecke D
MMW Fortschr Med; 2009 Apr; 151(16):10-1. PubMed ID: 19658286
[No Abstract] [Full Text] [Related]
13. [Platelet inhibition remains the second choice. "Anticoagulation should always be the goal" (interview by Dr. med. Jochen Aumiller)].
Connolly S
MMW Fortschr Med; 2009 Apr; 151(16):11. PubMed ID: 19658287
[No Abstract] [Full Text] [Related]
14. Antithrombotic therapy after myocardial infarction.
Becker RC
N Engl J Med; 2002 Sep; 347(13):1019-22. PubMed ID: 12324559
[No Abstract] [Full Text] [Related]
15. Anticoagulants and antiplatelet agents in acute ischemic stroke.
Pellegrino TR
Va Med Q; 1998; 125(2):125-7. PubMed ID: 9577715
[No Abstract] [Full Text] [Related]
16. CURE--clopidogrel's major advance.
Jackson G
Int J Clin Pract; 2001 Apr; 55(3):155. PubMed ID: 11351766
[No Abstract] [Full Text] [Related]
17. [Oral anticoagulation in activated protein C resistance?].
Stiegler H
Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1619. PubMed ID: 9011491
[No Abstract] [Full Text] [Related]
18. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
Rupprecht HJ
MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
[No Abstract] [Full Text] [Related]
19. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
Smith DA
Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
[No Abstract] [Full Text] [Related]
20. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
Pongrácz E
Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]